Moody's Upgrades Pharma Industry to Stable

FDA hits Unicycive with CRL due to third-party manufacturing issues

Axplora to invest $38M to expand API manufacturing site in Italy

Hikma commits $1B to expand US domestic manufacturing, development of generics

Aenova to boost cold chain capabilities with warehouse at sterile site in Italy